Walter Vidal Contreras Robles sat excitedly in the small waiting room of the UNLV Otolaryngology Clinic with a bright smile on his face on the morning of May 30.

Walter Vidal Contreras Robles sat excitedly in the small waiting room of UNLV’s otolaryngology clinic with a bright smile on his face the morning of May 30.

Busy Philipps and Ann Childress, MD, explore the unique challenges women face in ADHD diagnosis, highlighting personal stories and the importance of treatment.

It didn’t smell as bad as I thought it would. Sort of like going-bad ocean water but without the salt. It doesn’t look as nasty as I thought, either, but it’s important to maintain a sense of professional clinical distance even though I’m seeing and smelling the sewage of half a million people.

An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the development pipeline and offers optimism for the global effort to find a cure.

There are more potential new medicines being tested for Alzheimer’s disease, according to an annual review published today. It reports that 138 drugs are currently being tested – an increase of nearly 9% from last year. This is great news, because the more drugs that scientists test, the greater the chance that new and effective medicines will soon become a reality for people living with dementia.

Of all the medical challenges that scientists have faced, Alzheimer’s disease, the most common form of dementia, has been one of the trickiest. Between 1995 and 2021 private money spent on Alzheimer’s research totalled $42.5bn, but more than 140 trials failed to deliver a single drug capable of slowing the disease. Yet the tide may be turning. There are two working drugs, offering modest benefits, on the market. A new review paper suggests more could soon follow.

Should the 90 percent of Nevada parents who support sex education have to jump through hoops simply to ensure their children receive it? That’s the reality under our current opt-in policy, which creates unnecessary barriers to critical health education. AB205 offers a simple fix: Switch to an opt-out system to ensure all students receive necessary evidence-based instruction unless a parent actively withdraws them.

Newly updated data from the Centers for Disease Control show a 27% decline in overdose deaths in the U.S. in 2024, but during that 12-month period, Nevada saw a 3.4% increase. Experts say it’s happening despite growing efforts by law enforcement and advocates who educate the public about the dangers of opioids, fentanyl, and methamphetamines.

There appears to be a breakthrough in the fight against Alzheimer's. A new blood test that detects a distinct characteristic of the disease is likely going to change the way doctors diagnose and treat it.

Temperatures are heating up in the valley, and experts warn of a possible spike in gun violence during the summer months.

Temperatures are heating up in the valley, and experts warn of a possible spike in gun violence during the summer months.